The mouse HP1 proteins are essential for preventing liver tumorigenesis.


Journal

Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562

Informations de publication

Date de publication:
03 2020
Historique:
received: 01 04 2019
accepted: 21 01 2020
revised: 06 01 2020
pubmed: 6 2 2020
medline: 15 12 2020
entrez: 6 2 2020
Statut: ppublish

Résumé

Chromatin organization is essential for appropriate interpretation of the genetic information. Here, we demonstrated that the chromatin-associated proteins HP1 are dispensable for hepatocytes survival but are essential within hepatocytes to prevent liver tumor development in mice with HP1β being pivotal in these functions. Yet, we found that the loss of HP1 per se is not sufficient to induce cell transformation but renders cells more resistant to specific stress such as the expression of oncogenes and thus in fine, more prone to cell transformation. Molecular characterization of HP1-Triple KO premalignant livers and BMEL cells revealed that HP1 are essential for the maintenance of heterochromatin organization and for the regulation of specific genes with most of them having well characterized functions in liver functions and homeostasis. We further showed that some specific retrotransposons get reactivated upon loss of HP1, correlating with overexpression of genes in their neighborhood. Interestingly, we found that, although HP1-dependent genes are characterized by enrichment H3K9me3, this mark does not require HP1 for its maintenance and is not sufficient to maintain gene repression in absence of HP1. Finally, we demonstrated that the loss of TRIM28 association with HP1 recapitulated several phenotypes induced by the loss of HP1 including the reactivation of some retrotransposons and the increased incidence of liver cancer development. Altogether, our findings indicate that HP1 proteins act as guardians of liver homeostasis to prevent tumor development by modulating multiple chromatin-associated events within both the heterochromatic and euchromatic compartments, partly through regulation of the corepressor TRIM28 activity.

Identifiants

pubmed: 32020053
doi: 10.1038/s41388-020-1177-8
pii: 10.1038/s41388-020-1177-8
doi:

Substances chimiques

CBX1 protein, human 0
Chromosomal Proteins, Non-Histone 0
Heterochromatin 0
Retroelements 0
Chromobox Protein Homolog 5 107283-02-3
Trim28 protein, mouse EC 2.3.2.27
Tripartite Motif-Containing Protein 28 EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2676-2691

Références

Prakash K, Fournier D. Evidence for the implication of the histone code in building the genome structure. BioSystems. 2018;164:49–59.
doi: 10.1016/j.biosystems.2017.11.005 pubmed: 29158132 pmcid: 29158132
Koschmann C, Nunez FJ, Mendez F, Brosnan-Cashman JA, Meeker AK, Lowenstein PR, et al. Mutated chromatin regulatory factors as tumor drivers in cancer. Cancer Res. 2017;77:227–33.
doi: 10.1158/0008-5472.CAN-16-2301 pubmed: 28062403 pmcid: 28062403
Mirabella AC, Foster BM, Bartke T. Chromatin deregulation in disease. Chromosoma. 2016;125:75–93.
doi: 10.1007/s00412-015-0530-0 pubmed: 26188466 pmcid: 26188466
Mai S. The 3D cancer nucleus. Genes Chromosomes Cancer. 2018. https://doi.org/10.1002/gcc.22720 .
Janssen A, Colmenares SU, Karpen GH. Heterochromatin: guardian of the genome. Annu Rev Cell Dev Biol. 2018. https://doi.org/10.1146/annurev-cellbio-100617-062653 .
James TC, Elgin SC. Identification of a nonhistone chromosomal protein associated with heterochromatin in Drosophila melanogaster and its gene. Mol Cell Biol. 1986;6:3862–72.
doi: 10.1128/MCB.6.11.3862 pubmed: 3099166 pmcid: 3099166
Eissenberg JC, Elgin SCR. HP1a: a structural chromosomal protein regulating transcription. Trends Genet. 2014;30:103–10.
doi: 10.1016/j.tig.2014.01.002 pubmed: 24555990 pmcid: 24555990
Lomberk G, Wallrath L, Urrutia R. The heterochromatin protein 1 family. Genome Biol. 2006;7:228.
doi: 10.1186/gb-2006-7-7-228 pubmed: 17224041 pmcid: 17224041
Dinant C, Luijsterburg MS. The emerging role of HP1 in the DNA damage response. Mol Cell Biol. 2009;29:6335–40.
doi: 10.1128/MCB.01048-09 pubmed: 19805510 pmcid: 19805510
Fanti L, Pimpinelli S. HP1: a functionally multifaceted protein. Curr Opin Genet Dev. 2008;18:169–74.
doi: 10.1016/j.gde.2008.01.009 pubmed: 18329871 pmcid: 18329871
Nishibuchi G, Nakayama J. Biochemical and structural properties of heterochromatin protein 1: understanding its role in chromatin assembly. J Biochem. 2014;156:11–20.
doi: 10.1093/jb/mvu032 pubmed: 24825911 pmcid: 24825911
Shi S, Larson K, Guo D, Lim SJ, Dutta P, Yan S-J, et al. Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability. Nat Cell Biol. 2008;10:489–96.
doi: 10.1038/ncb1713 pubmed: 18344984 pmcid: 18344984
Bosch-Presegué L, Raurell-Vila H, Thackray JK, González J, Casal C, Kane-Goldsmith N, et al. Mammalian HP1 isoforms have specific roles in heterochromatin structure and organization. Cell Rep. 2017;21:2048–57.
doi: 10.1016/j.celrep.2017.10.092 pubmed: 29166597 pmcid: 29166597
Dialynas GK, Vitalini MW, Wallrath LL. Linking heterochromatin protein 1 (HP1) to cancer progression. Mutat Res. 2008;647:13–20.
doi: 10.1016/j.mrfmmm.2008.09.007 pubmed: 18926834 pmcid: 18926834
Vad-Nielsen J, Nielsen AL. Beyond the histone tale: HP1α deregulation in breast cancer epigenetics. Cancer Biol Ther. 2015;16:189–200.
doi: 10.1080/15384047.2014.1001277 pubmed: 25588111 pmcid: 25588111
Herquel B, Ouararhni K, Khetchoumian K, Ignat M, Teletin M, Mark M, et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011;108:8212–7.
doi: 10.1073/pnas.1101544108 pubmed: 21531907 pmcid: 21531907
Fan DN-Y, Tsang FH-C, Tam AH-K, Au SL-K, Wong CC-L, Wei L, et al. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Hepatology. 2013;57:637–47.
doi: 10.1002/hep.26083 pubmed: 22991213 pmcid: 22991213
Bojkowska K, Aloisio F, Cassano M, Kapopoulou A, Santoni de Sio F, Zangger N, et al. Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma. Hepatology. 2012;56:1279–90.
doi: 10.1002/hep.25767 pubmed: 22684873 pmcid: 22684873
Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, Ignat M, et al. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet. 2007;39:1500–6.
doi: 10.1038/ng.2007.15 pubmed: 18026104 pmcid: 18026104
Hardy T, Mann DA. Epigenetics in liver disease: from biology to therapeutics. Gut. 2016;65:1895–905.
doi: 10.1136/gutjnl-2015-311292 pubmed: 27624887 pmcid: 27624887
Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT, et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature. 2012;487:249–53.
doi: 10.1038/nature11173 pubmed: 22763435 pmcid: 22763435
Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274:305–15.
doi: 10.1074/jbc.274.1.305 pubmed: 9867845 pmcid: 9867845
Weisend CM, Kundert JA, Suvorova ES, Prigge JR, Schmidt EE. Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies. Genesis. 2009;47:789–92.
pubmed: 19830819 pmcid: 19830819
Kuo LJ, Yang L-X. Gamma-H2AX—a novel biomarker for DNA double-strand breaks. In Vivo. 2008;22:305–9.
pubmed: 18610740 pmcid: 18610740
Niu Z-S, Niu X-J, Wang W-H. Genetic alterations in hepatocellular carcinoma: an update. World J Gastroenterol. 2016;22:9069–95.
doi: 10.3748/wjg.v22.i41.9069 pubmed: 27895396 pmcid: 27895396
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.
doi: 10.1002/hep.24199 pubmed: 21374666 pmcid: 21374666
Strick-Marchand H, Weiss MC. Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology. 2002;36:794–804.
doi: 10.1053/jhep.2002.36123 pubmed: 12297826 pmcid: 12297826
Guengerich FP. Cytochrome P450 research and the journal of biological chemistry. J Biol Chem. 2018. https://doi.org/10.1074/jbc.TM118.004144 .
Bhattacharyya S, Sinha K, Sil PC. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress. Curr Drug Metab. 2014;15:719–42.
doi: 10.2174/1389200215666141125121659 pubmed: 25429675 pmcid: 25429675
Park JW, Reed JR, Brignac-Huber LM, Backes WL. Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum. Biochem J. 2014;464:241–9.
doi: 10.1042/BJ20140787 pubmed: 25236845 pmcid: 25236845
Paik Y-H, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal. 2014;20:2854–72.
doi: 10.1089/ars.2013.5619 pubmed: 24040957 pmcid: 24040957
Yang P, Wang Y, Macfarlan TS. The role of KRAB-ZFPs in transposable element repression and mammalian evolution. Trends Genet. 2017;33:871–81.
doi: 10.1016/j.tig.2017.08.006 pubmed: 28935117 pmcid: 28935117
O’Geen H, Squazzo SL, Iyengar S, Blahnik K, Rinn JL, Chang HY, et al. Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet. 2007;3:e89.
doi: 10.1371/journal.pgen.0030089 pubmed: 17542650 pmcid: 17542650
Ecco G, Cassano M, Kauzlaric A, Duc J, Coluccio A, Offner S, et al. Transposable elements and their KRAB-ZFP controllers regulate gene expression in adult tissues. Dev Cell. 2016;36:611–23.
doi: 10.1016/j.devcel.2016.02.024 pubmed: 27003935 pmcid: 27003935
Herquel B, Ouararhni K, Martianov I, Le Gras S, Ye T, Keime C, et al. Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA. Nat Struct Mol Biol. 2013;20:339–46.
doi: 10.1038/nsmb.2496 pubmed: 23377542 pmcid: 23377542
Ecco G, Imbeault M, Trono D. KRAB zinc finger proteins. Development. 2017;144:2719–29.
doi: 10.1242/dev.132605 pubmed: 28765213 pmcid: 28765213
Herzog M, Wendling O, Guillou F, Chambon P, Mark M, Losson R, et al. TIF1β association with HP1 is essential for post-gastrulation development, but not for Sertoli cell functions during spermatogenesis. Dev Biol. 2011;350:548–58.
doi: 10.1016/j.ydbio.2010.12.014 pubmed: 21163256 pmcid: 21163256
Huang C, Su T, Xue Y, Cheng C, Lay FD, McKee RA, et al. Cbx3 maintains lineage specificity during neural differentiation. Genes Dev. 2017;31:241–6.
doi: 10.1101/gad.292169.116 pubmed: 28270516 pmcid: 28270516
Mattout A, Aaronson Y, Sailaja BS, Raghu Ram EV, Harikumar A, Mallm J-P et al. Heterochromatin Protein 1β (HP1β) has distinct functions and distinct nuclear distribution in pluripotent versus differentiated cells. Genome Biol. 2015;16. https://doi.org/10.1186/s13059-015-0760-8 .
Eissenberg JC, Morris GD, Reuter G, Hartnett T. The heterochromatin-associated protein HP-1 is an essential protein in Drosophila with dosage-dependent effects on position-effect variegation. Genetics. 1992;131:345–52.
pubmed: 1644277 pmcid: 1644277
Schott S, Coustham V, Simonet T, Bedet C, Palladino F. Unique and redundant functions of C. elegans HP1 proteins in post-embryonic development. Dev Biol. 2006;298:176–87.
doi: 10.1016/j.ydbio.2006.06.039 pubmed: 16905130 pmcid: 16905130
Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–53.
doi: 10.1002/hep.20969 pubmed: 16447274 pmcid: 16447274
Kurinna S, Barton MC. Cascades of transcription regulation during liver regeneration. Int J Biochem Cell Biol. 2011;43:189–97.
doi: 10.1016/j.biocel.2010.03.013 pubmed: 20307684 pmcid: 20307684
Lee Y-H, Ann DK. Bi-phasic expression of heterochromatin protein 1 (HP1) during breast cancer progression: potential roles of HP1 and chromatin structure in tumorigenesis. J Nat Sci. 2015;1:e127.
pubmed: 26082944 pmcid: 26082944
Towbin BD, González-Aguilera C, Sack R, Gaidatzis D, Kalck V, Meister P, et al. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell. 2012;150:934–47.
doi: 10.1016/j.cell.2012.06.051 pubmed: 22939621 pmcid: 22939621
Poleshko A, Mansfield KM, Burlingame CC, Andrake MD, Shah NR, Katz RA. The human protein PRR14 tethers heterochromatin to the nuclear lamina during interphase and mitotic exit. Cell Rep. 2013;5:292–301.
doi: 10.1016/j.celrep.2013.09.024 pubmed: 24209742 pmcid: 24209742
Lehnertz B, Ueda Y, Derijck AAHA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003;13:1192–1200.
doi: 10.1016/S0960-9822(03)00432-9 pubmed: 12867029 pmcid: 12867029
Velazquez Camacho O, Galan C, Swist-Rosowska K, Ching R, Gamalinda M, Karabiber F, et al. Major satellite repeat RNA stabilize heterochromatin retention of Suv39h enzymes by RNA-nucleosome association and RNA:DNA hybrid formation. Elife. 2017;6. https://doi.org/10.7554/eLife.25293 .
Pogribny IP, Ross SA, Tryndyak VP, Pogribna M, Poirier LA, Karpinets TV. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis. 2006;27:1180–6.
doi: 10.1093/carcin/bgi364 pubmed: 16497704 pmcid: 16497704
Brustel J, Kirstein N, Izard F, Grimaud C, Prorok P, Cayrou C, et al. Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication. EMBO J. 2017;36:2726–41.
doi: 10.15252/embj.201796541 pubmed: 28778956 pmcid: 28778956
Jørgensen S, Schotta G, Sørensen CS. Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity. Nucleic Acids Res. 2013;41:2797–806.
doi: 10.1093/nar/gkt012 pubmed: 23345616 pmcid: 23345616
Du Q, Bert SA, Armstrong NJ, Caldon CE, Song JZ, Nair SS, et al. Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer. Nat Commun. 2019;10:416.
doi: 10.1038/s41467-019-08302-1 pubmed: 30679435 pmcid: 30679435
Lee DH, Li Y, Shin D-H, Yi SA, Bang S-Y, Park EK, et al. DNA microarray profiling of genes differentially regulated by three heterochromatin protein 1 (HP1) homologs in Drosophila. Biochem Biophys Res Commun. 2013;434:820–8.
doi: 10.1016/j.bbrc.2013.04.020 pubmed: 23611785 pmcid: 23611785
Piacentini L, Fanti L, Negri R, Del Vescovo V, Fatica A, Altieri F, et al. Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in Drosophila. PLoS Genet. 2009;5:e1000670.
doi: 10.1371/journal.pgen.1000670 pubmed: 19798443 pmcid: 19798443
Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell. 2005;19:381–91.
doi: 10.1016/j.molcel.2005.06.011 pubmed: 16061184 pmcid: 16061184
Stunnenberg R, Kulasegaran-Shylini R, Keller C, Kirschmann MA, Gelman L, Bühler M. H3K9 methylation extends across natural boundaries of heterochromatin in the absence of an HP1 protein. EMBO J. 2015;34:2789–803.
doi: 10.15252/embj.201591320 pubmed: 26438724 pmcid: 26438724
Takaki A, Yamamoto K. Control of oxidative stress in hepatocellular carcinoma: helpful or harmful? World J Hepatol. 2015;7:968–79.
doi: 10.4254/wjh.v7.i7.968 pubmed: 25954479 pmcid: 25954479
Cizkova K, Konieczna A, Erdosova B, Lichnovska R, Ehrmann J. Peroxisome proliferator-activated receptors in regulation of cytochromes P450: new way to overcome multidrug resistance? J Biomed Biotechnol. 2012;2012. https://doi.org/10.1155/2012/656428 .
Del Campo JA, Gallego P, Grande L. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol. 2018;10:1–7.
doi: 10.4254/wjh.v10.i1.1 pubmed: 29399273 pmcid: 29399273
Bishayee A. The role of inflammation and liver cancer. Adv Exp Med Biol. 2014;816:401–35.
doi: 10.1007/978-3-0348-0837-8_16 pubmed: 24818732 pmcid: 24818732
Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014;342:223–30.
doi: 10.1016/j.canlet.2012.01.038 pubmed: 22306342 pmcid: 22306342
Brégnard C, Guerra J, Déjardin S, Passalacqua F, Benkirane M, Laguette N. Upregulated LINE-1 activity in the fanconi anemia cancer susceptibility syndrome leads to spontaneous pro-inflammatory cytokine production. EBioMedicine. 2016;8:184–94.
doi: 10.1016/j.ebiom.2016.05.005 pubmed: 27428429 pmcid: 27428429
Matsui T, Leung D, Miyashita H, Maksakova IA, Miyachi H, Kimura H, et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature. 2010;464:927–31.
doi: 10.1038/nature08858 pubmed: 20164836 pmcid: 20164836
Kato M, Takemoto K, Shinkai Y. A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing. Nat Commun. 2018;9:1683.
doi: 10.1038/s41467-018-04132-9 pubmed: 5923290 pmcid: 5923290
Jacobs FMJ, Greenberg D, Nguyen N, Haeussler M, Ewing AD, Katzman S, et al. An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons. Nature. 2014;516:242–5.
doi: 10.1038/nature13760 pubmed: 25274305 pmcid: 25274305
Wolf G, Yang P, Füchtbauer AC, Füchtbauer E-M, Silva AM, Park C, et al. The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses. Genes Dev. 2015;29:538–54.
doi: 10.1101/gad.252767.114 pubmed: 25737282 pmcid: 25737282
Cammas F, Mark M, Dollé P, Dierich A, Chambon P, Losson R. Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development. Development. 2000;127:2955–63.
pubmed: 10851139 pmcid: 10851139

Auteurs

Nehmé Saksouk (N)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Shefqet Hajdari (S)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Yannick Perez (Y)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Marine Pratlong (M)

MGX, Biocampus Montpellier, CNRS, INSERM, University of Montpellier, Montpellier, France.

Célia Barrachina (C)

MGX, Biocampus Montpellier, CNRS, INSERM, University of Montpellier, Montpellier, France.

Céline Graber (C)

IGBMC, Institut de Génétique, de Biologie Moléculaire et Cellulaire, Illkirch, France.

Damien Grégoire (D)

CNRS, Route de Mende, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Aliki Zavoriti (A)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Amélie Sarrazin (A)

IGBMC, Institut de Génétique, de Biologie Moléculaire et Cellulaire, Illkirch, France.
MRI, BioCampus Montpellier, CNRS, INSERM, University of Montpellier, Montpellier, France.

Nelly Pirot (N)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Jean-Yohan Noël (JY)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Lakhdar Khellaf (L)

Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.

Eric Fabbrizio (E)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.
CNRS, Route de Mende, Montpellier, France.

Eric Julien (E)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France.
INSERM, U1194, F-34298, Montpellier, France.
Université de Montpellier, F-34090, Montpellier, France.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France.
CNRS, Route de Mende, Montpellier, France.

Florence M Cammas (FM)

IRCM, Institut de Recherche en Cancérologie de Montpellier, F-34298, Montpellier, France. Florence.cammas@inserm.fr.
INSERM, U1194, F-34298, Montpellier, France. Florence.cammas@inserm.fr.
Université de Montpellier, F-34090, Montpellier, France. Florence.cammas@inserm.fr.
Institut régional du Cancer de Montpellier, F-34298, Montpellier, France. Florence.cammas@inserm.fr.
CNRS, Route de Mende, Montpellier, France. Florence.cammas@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH